Internal Medicine · San Antonio, TX
NPI
1528171451
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
1303 McCullough Ave, Suite 428
San Antonio, TX, 78212
Phone (210) 225-2229
Medicare paid, 2024
$51K
774 services
Medicare patients, 2024
70
Average age 70
Drug cost, 2024
$399K
1,005 prescriptions
Company payments, 2025
$37.85
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto Trevino, Jr. was code 99232 (hospital e&m - subsequent), 648 times for 55 patients. In total Roberto Trevino, Jr. billed 774 services in 6 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 648 | 55 | $59.47 | $39K |
| 99223 Hospital E&M - Initial | Facility | 53 | 52 | $127.95 | $6,781 |
By year: 2022 $125K for 2,112 services; 2023 $122K for 1,892 services; 2024 $51K for 774 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roberto Trevino, Jr. prescribed most often to Medicare patients was Emtricitabine-Tenofovir Disop (Emtricitabine/Tenofovir (Tdf)), with 69 prescriptions and refills. In total Roberto Trevino, Jr. wrote 1,005 Medicare prescriptions that cost $399K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 69 | 69 | Under 11 | $14K |
| Azithromycin Generic | 67 | 67 | 21 | $423 |
| Metformin Hcl Generic | 62 | 104 | 13 | $209 |
| Atorvastatin Calcium Generic | 52 | 82 | Under 11 | $203 |
| Lopinavir-Ritonavir Lopinavir/Ritonavir | 48 | 48 | Under 11 | $37K |
| Lisinopril Generic | 43 | 71 | Under 11 | $141 |
| Ritonavir Generic | 41 | 45 | Under 11 | $3,023 |
| Rosuvastatin Calcium Generic | 35 | 71 | Under 11 | $99.39 |
| Fosamprenavir Calcium Generic | 25 | 26 | Under 11 | $25K |
| Lamivudine-Zidovudine Lamivudine/Zidovudine | 24 | 24 | Under 11 | $4,361 |
| Hydrochlorothiazide Generic | 24 | 44 | Under 11 | $43.81 |
| Tivicay Dolutegravir Sodium | 23 | 23 | Under 11 | $102K |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 21 | 21 | Under 11 | $20K |
| Omeprazole Generic | 21 | 44 | Under 11 | $196 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 21 | 21 | Under 11 | $78K |
Brand drugs: 145 claims; generic drugs: 846 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto Trevino, Jr. $37.85 ($37.85 in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $21.18.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.